If biomolecules were people, heparin would be a celebrity. Best known as a powerful blood thinner with a global market of more than $7 billion, heparin is used during and after surgery and is essential to kidney dialysis. Most of today’s heparin comes from pigs, but the Food and Drug Administration is encouraging the use of alternative sources, including cows and synthetic forms of heparin, to diversify the supply chain.